{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:00:02Z","timestamp":1793325602518,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-92099-1","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T13:16:41Z","timestamp":1741180601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cost-effectiveness of HIV pre-exposure prophylaxis among female sex workers in Iran"],"prefix":"10.1038","volume":"15","author":[{"given":"Hossein","family":"Moameri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Goudarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Akbar","family":"Haghdoost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mehdi","family":"Gouya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parya","family":"Saberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mirzazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvin Mangolian","family":"Shahrbabaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"92099_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1071\/SH18125","volume":"15","author":"I Hodges-Mameletzis","year":"2018","unstructured":"Hodges-Mameletzis, I., Dalal, S., Msimanga-Radebe, B., Rodolph, M. & Baggaley, R. Going global: the adoption of the world health organization\u2019s enabling recommendation on oral pre-exposure prophylaxis for HIV. Sex. Health. 15, 489\u2013500 (2018).","journal-title":"Sex. Health"},{"key":"92099_CR2","doi-asserted-by":"publisher","first-page":"S301","DOI":"10.1093\/infdis\/jiaa130","volume":"222","author":"E Krebs","year":"2020","unstructured":"Krebs, E. et al. Ending the HIV epidemic among persons who inject drugs: a cost-effectiveness analysis in six US cities. J. Infect. Dis. 222, S301\u2013S311 (2020).","journal-title":"J. Infect. Dis."},{"key":"92099_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","volume":"387","author":"S McCormack","year":"2016","unstructured":"McCormack, S. et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet 387, 53\u201360 (2016).","journal-title":"Lancet"},{"key":"92099_CR4","doi-asserted-by":"publisher","first-page":"e048478","DOI":"10.1136\/bmjopen-2020-048478","volume":"12","author":"EO Murchu","year":"2022","unstructured":"Murchu, E. O. et al. Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations. BMJ Open. 12, e048478 (2022).","journal-title":"BMJ Open."},{"key":"92099_CR5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3389\/fphar.2018.00799","volume":"9","author":"X Huang","year":"2018","unstructured":"Huang, X. et al. Efficacy and safety of oral TDF-based pre-exposure prophylaxis for men who have sex with men: a systematic review and meta-analysis. Front. Pharmacol. 9, 799 (2018).","journal-title":"Front. Pharmacol."},{"key":"92099_CR6","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","volume":"30","author":"VA Fonner","year":"2016","unstructured":"Fonner, V. A. et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS (London England). 30, 1973 (2016).","journal-title":"AIDS (London England)"},{"key":"92099_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","volume":"367","author":"MC Thigpen","year":"2012","unstructured":"Thigpen, M. C. et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N. Engl. J. Med. 367, 423\u2013434 (2012).","journal-title":"N. Engl. J. Med."},{"key":"92099_CR8","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","volume":"381","author":"K Choopanya","year":"2013","unstructured":"Choopanya, K. et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 381, 2083\u20132090 (2013).","journal-title":"Lancet"},{"key":"92099_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten, J. M. et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N. Engl. J. Med. 367, 399\u2013410 (2012).","journal-title":"N. Engl. J. Med."},{"key":"92099_CR10","doi-asserted-by":"publisher","first-page":"e040701","DOI":"10.1136\/bmjopen-2020-040701","volume":"11","author":"M Cabecinha","year":"2021","unstructured":"Cabecinha, M. et al. Equity considerations in outcome measures of the HIV pre-exposure prophylaxis care continuum in high-income countries: a systematic review protocol. BMJ Open. 11, e040701 (2021).","journal-title":"BMJ Open."},{"key":"92099_CR11","first-page":"A105","volume":"97","author":"M Cabecinha","year":"2021","unstructured":"Cabecinha, M., Solomon, D., Rait, G., Saunders, J. & Mohammed, H. P182 identifying the PrEP Gap: A systematic review exploring equity in the HIV-PrEP care continuum in high income countries. Sex. Transm. Infect. 97, A105\u2013A106 (2021).","journal-title":"Sex. Transm. Infect."},{"key":"92099_CR12","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/QAI.0000000000000993","volume":"72","author":"DT Dimitrov","year":"2016","unstructured":"Dimitrov, D. T., M\u00e2sse, B. R. & Donnell, D. PrEP adherence patterns strongly affect individual HIV risk and observed efficacy in randomized clinical trials. JAIDS J. Acquir. Immune Defic. Syndr. 72, 444\u2013451 (2016).","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"92099_CR13","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1097\/QAD.0000000000001519","volume":"31","author":"L Lal","year":"2017","unstructured":"Lal, L. et al. Medication adherence, condom use and sexually transmitted infections in Australian preexposure prophylaxis users. Aids 31, 1709\u20131714 (2017).","journal-title":"Aids"},{"key":"92099_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.epidem.2015.10.002","volume":"14","author":"Z Mukandavire","year":"2016","unstructured":"Mukandavire, Z., Mitchell, K. M. & Vickerman, P. Comparing the impact of increasing condom use or HIV pre-exposure prophylaxis (PrEP) use among female sex workers. Epidemics 14, 62\u201370 (2016).","journal-title":"Epidemics"},{"key":"92099_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-018-3463-4","volume":"18","author":"D Sidebottom","year":"2018","unstructured":"Sidebottom, D., Ekstr\u00f6m, A. M. & Str\u00f6mdahl, S. A systematic review of adherence to oral pre-exposure prophylaxis for HIV\u2013how can we improve uptake and adherence? BMC Infect. Dis. 18, 1\u201314 (2018).","journal-title":"BMC Infect. Dis."},{"key":"92099_CR16","doi-asserted-by":"publisher","first-page":"e26110","DOI":"10.1002\/jia2.26110","volume":"26","author":"D Castor","year":"2023","unstructured":"Castor, D. et al. Implementation and resource needs for long-acting PrEP in low\u2010and middle\u2010income countries: a scoping review. J. Int. AIDS. Soc. 26, e26110 (2023).","journal-title":"J. Int. AIDS. Soc."},{"key":"92099_CR17","unstructured":"UNAIDS. HIV and sex work \u2014 Human rights fact sheet series 2021, (2021). https:\/\/www.unaids.org\/en\/resources\/documents\/2021\/05-hiv-human-rights-factsheet-sex-work"},{"key":"92099_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(14)60931-4","volume":"385","author":"K Shannon","year":"2015","unstructured":"Shannon, K. et al. Global epidemiology of HIV among female sex workers: influence of structural determinants. Lancet 385, 55\u201371 (2015).","journal-title":"Lancet"},{"key":"92099_CR19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/QAD.0000000000002757","volume":"35","author":"S SeyedAlinaghi","year":"2021","unstructured":"SeyedAlinaghi, S. et al. HIV in Iran: onset, responses, and future directions. Aids 35, 529\u2013542 (2021).","journal-title":"Aids"},{"key":"92099_CR20","doi-asserted-by":"publisher","first-page":"e0207681","DOI":"10.1371\/journal.pone.0207681","volume":"13","author":"H Sharifi","year":"2018","unstructured":"Sharifi, H. et al. Estimation of HIV incidence and its trend in three key populations in Iran. PloS One. 13, e0207681 (2018).","journal-title":"PloS One"},{"key":"92099_CR21","unstructured":"CDC. Preventing New HIV Infections, (2021). https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2021.pdf"},{"key":"92099_CR22","unstructured":"WHO. Differentiated and simplified pre-exposure prophylaxis for HIV prevention: update to WHO implementation guidance: technical brief, (2022). https:\/\/www.who.int\/publications\/i\/item\/9789240053694"},{"key":"92099_CR23","doi-asserted-by":"publisher","first-page":"e629","DOI":"10.1016\/S2352-3018(18)30215-7","volume":"5","author":"AE Grulich","year":"2018","unstructured":"Grulich, A. E. et al. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Lancet HIV. 5, e629\u2013e637 (2018).","journal-title":"Lancet HIV"},{"key":"92099_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/QAI.0000000000000461","volume":"68","author":"DK Smith","year":"2015","unstructured":"Smith, D. K., Herbst, J. H., Zhang, X. & Rose, C. E. Condom effectiveness for HIV prevention by consistency of use among men who have sex with men in the united States. JAIDS J. Acquir. Immune Defic. Syndr. 68, 337\u2013344 (2015).","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"92099_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-021-00392-6","volume":"18","author":"H Zhao","year":"2021","unstructured":"Zhao, H. et al. A systematic and meta-analysis of heterosexual behaviors and HIV prevalence among Chinese men who have sex with men. AIDS Res. Therapy. 18, 1\u201313 (2021).","journal-title":"AIDS Res. Therapy"},{"key":"92099_CR26","unstructured":"UNAIDS. Country factsheets, Iran(Islamic Republic Of), (2022). https:\/\/www.unaids.org\/en\/regionscountries\/countries\/islamicrepublicofiran"},{"key":"92099_CR27","doi-asserted-by":"publisher","first-page":"e25883","DOI":"10.1002\/jia2.25883","volume":"25","author":"Z Sun","year":"2022","unstructured":"Sun, Z. et al. Increasing awareness of HIV pre-exposure prophylaxis (PrEP) and willingness to use HIV PrEP among men who have sex with men: a systematic review and meta\u2010analysis of global data. J. Int. AIDS. Soc. 25, e25883 (2022).","journal-title":"J. Int. AIDS. Soc."},{"key":"92099_CR28","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/cid\/ciy182","volume":"67","author":"MW Traeger","year":"2018","unstructured":"Traeger, M. W. et al. Effects of pre-exposure prophylaxis for the prevention of human immunodeficiency virus infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis. Clin. Infect. Dis. 67, 676\u2013686 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"92099_CR29","doi-asserted-by":"publisher","first-page":"e303","DOI":"10.1016\/S2352-3018(17)30045-0","volume":"4","author":"B Nosyk","year":"2017","unstructured":"Nosyk, B. et al. Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, Canada, 1996\u20132013: a modelling study. Lancet HIV. 4, e303\u2013e310 (2017).","journal-title":"Lancet HIV"},{"key":"92099_CR30","unstructured":"Fox-Rushby, J. & Cairns, J. Economic evaluation. Vol. 1 66 (McGraw-Hill Education (UK), (2005)."},{"key":"92099_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-7547-12-1","volume":"12","author":"SW Kim","year":"2014","unstructured":"Kim, S. W., Pulkki-Brannstrom, A. M. & Skordis-Worrall, J. Comparing the cost effectiveness of harm reduction strategies: a case study of the Ukraine. Cost Eff. Resource Allocation. 12, 1\u201313 (2014).","journal-title":"Cost Eff. Resource Allocation"},{"key":"92099_CR32","unstructured":"Institute for health metrics and evaluation (IHME). Global Burden of Disease, GBD compare, (2019). https:\/\/vizhub.healthdata.org\/gbd-compare\/"},{"key":"92099_CR33","unstructured":"WHO. (2021). https:\/\/www.who.int\/news-room\/feature-stories\/detail\/new-cost-effectiveness-updates-from-who-choice.)."},{"key":"92099_CR34","unstructured":"World Bank. Open Data, Iran, Islamic Rep, (2022). https:\/\/data.worldbank.org\/country\/iran-islamic-rep?view=chart"},{"key":"92099_CR35","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1177\/0272989X221100112","volume":"42","author":"HB Wolff","year":"2022","unstructured":"Wolff, H. B., Qendri, V., Kunst, N., Alarid-Escudero, F. & Coup\u00e9, V. M. Methods for communicating the impact of parameter uncertainty in a multiple-strategies cost-effectiveness comparison. Med. Decis. Making. 42, 956\u2013968 (2022).","journal-title":"Med. Decis. Making"},{"key":"92099_CR36","doi-asserted-by":"publisher","first-page":"A73","DOI":"10.1089\/aid.2014.5136.abstract","volume":"30","author":"KM Mitchell","year":"2014","unstructured":"Mitchell, K. M. et al. Mathematical modelling to estimate the impact and Cost-effectiveness of TasP, PrEP and condom promotion for serodiscordant couples in Nigeria. AIDS Res. Hum. Retroviruses. 30, A73\u2013A73 (2014).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"92099_CR37","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1136\/sextrans-2012-050891","volume":"89","author":"S Verguet","year":"2013","unstructured":"Verguet, S., Stalcup, M. & Walsh, J. A. Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa? Sex. Transm. Infect. 89, 628\u2013634 (2013).","journal-title":"Sex. Transm. Infect."},{"key":"92099_CR38","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1521\/aeap.2019.31.5.421","volume":"31","author":"J Shea","year":"2019","unstructured":"Shea, J. et al. The drug will help protect my tomorrow: perceptions of integrating PrEP into HIV prevention behaviors among female sex workers in Lilongwe, Malawi. AIDS Educ. Prev. 31, 421\u2013432. https:\/\/doi.org\/10.1521\/aeap.2019.31.5.421 (2019).","journal-title":"AIDS Educ. Prev."},{"key":"92099_CR39","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/QAI.0000000000002327","volume":"84","author":"M Vogelzang","year":"2020","unstructured":"Vogelzang, M. et al. Cost-effectiveness of HIV pre-exposure prophylaxis among heterosexual men in South Africa: a cost-utility modeling analysis. JAIDS J. Acquir. Immune Defic. Syndr. 84, 173\u2013181 (2020).","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"92099_CR40","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1097\/QAD.0000000000002486","volume":"34","author":"L Jamieson","year":"2020","unstructured":"Jamieson, L. et al. The impact of self-selection based on HIV risk on the cost-effectiveness of preexposure prophylaxis in South Africa. Aids 34, 883\u2013891 (2020).","journal-title":"Aids"},{"key":"92099_CR41","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.jval.2016.02.017","volume":"19","author":"B Woods","year":"2016","unstructured":"Woods, B., Revill, P., Sculpher, M. & Claxton, K. Country-level cost-effectiveness thresholds: initial estimates and the need for further research. Value Health. 19, 929\u2013935 (2016).","journal-title":"Value Health"},{"key":"92099_CR42","first-page":"52","volume":"6","author":"A Mirahmadizadeh","year":"2018","unstructured":"Mirahmadizadeh, A., Majdzadeh, R. & Mohammad, K. Cost-effectiveness analysis of HIV\/AIDS prevention among intravenous drug users in Iran\u2019s Drop-in centers. J. Health Sci. Surveillance Syst. 6, 52\u201357 (2018).","journal-title":"J. Health Sci. Surveillance Syst."},{"key":"92099_CR43","doi-asserted-by":"publisher","first-page":"e1002444","DOI":"10.1371\/journal.pmed.1002444","volume":"14","author":"R Eakle","year":"2017","unstructured":"Eakle, R. et al. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: results from a prospective observational demonstration project. PLoS Med. 14, e1002444 (2017).","journal-title":"PLoS Med."},{"key":"92099_CR44","doi-asserted-by":"crossref","unstructured":"Cianci, F. et al. Modelling the cost-effectiveness of TasP and PrEP in female sex workers in Cotonou, Benin. medRxiv, 2012. 2006.23299621 (2023). (2023).","DOI":"10.1101\/2023.12.06.23299621"},{"key":"92099_CR45","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10461-021-03367-w","volume":"26","author":"C Mangenah","year":"2022","unstructured":"Mangenah, C. et al. Efficiency in PrEP delivery: estimating the annual costs of oral PrEP in Zimbabwe. AIDS Behav. 26, 161\u2013170 (2022).","journal-title":"AIDS Behav."},{"key":"92099_CR46","unstructured":"WHO. The World Health Report 2002: Reducing Risks, Promoting Healthy Life (World Health Organization, 2002)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92099-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92099-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92099-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:36:16Z","timestamp":1741221376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92099-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92099"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-92099-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7747"}}